Harald Binder
Overview
Explore the profile of Harald Binder including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
258
Citations
5383
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Hackenberg M, Brunn N, Vogel T, Binder H
Commun Biol
. 2025 Mar;
8(1):414.
PMID: 40069486
Dimensionality reduction greatly facilitates the exploration of cellular heterogeneity in single-cell RNA sequencing data. While most of such approaches are data-driven, it can be useful to incorporate biologically plausible assumptions...
2.
Rimner A, Dejonckheere C, Sahlmann J, Barth S, Schimek-Jasch T, Adebahr S, et al.
Int J Radiat Oncol Biol Phys
. 2025 Mar;
PMID: 40054586
Purpose: To evaluate the role of different invasive and non-invasive mediastinal staging methods in patients with locally advanced non-small-cell lung cancer (NSCLC) treated with definitive chemoradiotherapy in the prospective XXX...
3.
Pfaffenlehner M, Behrens M, Zoller D, Ungethum K, Gunther K, Rucker V, et al.
BMC Med Res Methodol
. 2025 Jan;
25(1):8.
PMID: 39810151
Background: The integration of real-world evidence (RWE) from real-world data (RWD) in clinical research is crucial for bridging the gap between clinical trial results and real-world outcomes. Analyzing routinely collected...
4.
Siemens W, von Elm E, Binder H, Bohringer D, Eisele-Metzger A, Gartlehner G, et al.
BMJ Evid Based Med
. 2025 Jan;
PMID: 39788693
No abstract available.
5.
Konstantinides S, Christodoulou K, Christodoulou K, Mohr K, Uphaus T, Jagersberg M, et al.
Thromb Haemost
. 2025 Jan;
PMID: 39778590
No abstract available.
6.
Ruhle A, Weymann M, Behrens M, Olbrich J, Kut C, Marschner S, et al.
Radiother Oncol
. 2024 Dec;
204:110697.
PMID: 39725066
Purpose: Cumulative cisplatin doses of ≥ 200 mg/m improve survival in adults with head-and-neck squamous cell carcinoma (HNSCC) undergoing chemoradiation, but many older adults with HNSCC cannot receive this prognostically...
7.
Hackenberg M, Pfaffenlehner M, Behrens M, Pechmann A, Kirschner J, Binder H
Biom J
. 2024 Dec;
67(1):e70023.
PMID: 39698740
In a longitudinal clinical registry, different measurement instruments might have been used for assessing individuals at different time points. To combine them, we investigate deep learning techniques for obtaining a...
8.
Fichtner U, Knaus J, Graf E, Koch G, Sahlmann J, Stelzer D, et al.
PLoS One
. 2024 Dec;
19(12):e0308375.
PMID: 39630700
Background: The advancement of Artificial Intelligence, particularly Large Language Models (LLMs), is rapidly progressing. LLMs, such as OpenAI's GPT, are becoming vital in scientific and medical processes, including text production,...
9.
Farhadyar K, Bonofiglio F, Hackenberg M, Behrens M, Zoller D, Binder H
BMC Med Res Methodol
. 2024 Sep;
24(1):198.
PMID: 39251921
In settings requiring synthetic data generation based on a clinical cohort, e.g., due to data protection regulations, heterogeneity across individuals might be a nuisance that we need to control or...
10.
Gkika E, Dejonckheere C, Sahlmann J, Barth S, Schimek-Jasch T, Adebahr S, et al.
Radiother Oncol
. 2024 Sep;
200:110521.
PMID: 39236984
Purpose: The aim of this secondary analysis of the prospective randomized phase 2 PET-Plan trial (ARO-2009-09; NCT00697333) was to evaluate the impact of mediastinal tumor burden and lymphatic spread in...